Impact of reimbursement program on liver-related mortality in patients with chronic hepatitis B in Beijing, China.

Min Li Yuan Yuan KongShan Shan WuJia Ling ZhouXiao Ning WuLin WangJian Ting SuXiao Juan OuHong YouXue Qin XieZai Hua WeiJi-Dong Jia

Published in: Journal of digestive diseases (2019)

Coverage of antiviral therapy by basic medical insurance reduced the risk of developing liver-related death for patients with non-cirrhotic and with compensated cirrhotic CHB.

Keyphrases

healthcare
affordable care act
hepatitis b virus
air pollution
cardiovascular events
type diabetes
particulate matter
health insurance
risk factors
cardiovascular disease
cell therapy